Leading Pharma, based in Airfield, NJ, operates as a vertically-integrated generic pharmaceutical company with internal R&D capabilities and a 53,000 square foot manufacturing plant dedicated to oral solid pharmaceuticals. Led by Co-Founder and CEO Ronald Gold, the company purchases, licenses, develops, manufactures and distributes products across many therapeutic areas under the Leading Pharma label. Since acquiring Excellium Pharmaceutical in 2014, it evolved from outsourcing development to having in-house R&D and manufacturing. The company sells to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S. The recent financing will support R&D investments to expand its diverse pipeline of generic products. Management also intends to use proceeds to repay existing indebtedness.

Total raised

$40M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2018